# A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)

> **NCT01891331** · PHASE2 · COMPLETED · sponsor: **Viamet** · enrollment: 55 (actual)

## Conditions studied

- Candidiasis, Vulvovaginal

## Interventions

- **DRUG:** VT-1161
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT01891331
- **Lead sponsor:** Viamet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891331, "A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01891331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*